Effects of Platelet-Activating Factor on Rat Airways
Open Access
- 1 January 1988
- journal article
- research article
- Published by Elsevier in The Japanese Journal of Pharmacology
- Vol. 48 (1) , 7-13
- https://doi.org/10.1254/jjp.48.7
Abstract
Effects of platelet-activating factor (PAF) on the rat airways were investigated. Male Wistar rats were anesthetized, and PAF was inhaled into the lungs through a tracheal cannula for 5 min using an ultrasonic nebulizer. The bronchomotor response was measured with a modified Konzett-Rossler method in rats immobilized with decamethonium bromide. The inhalation of PAF caused a marked bronchoconstriction, dose-dependently, in a concentration range of 0.0001 to 0.01%. The bronchoconstrictor potency of PAF was about ten times higher than that of ACh. On the other hand, histamine inhalation gave only a slight bronchoconstriction even at the high concentration of 0.1%. The bronchomotor response to PAF was accompanied by a marked, sustained decrease in systemic blood pressure, in a dose-dependent manner. Repeated inhalations of PAF (0.001%) at an interval of 60 min resulted in a pronounced tachyphylaxis in the bronchoconstrictor response, but not in the hypotensive response. Combined inhalations of PAF with ACh or histamine did not produce a potentiation by PAF of the bronchoconstrictor responses to ACh and histamine. These findings show that PAF is a strong bronchoconstrictor agent in rat and that there is no interaction between PAF and other mediators in the acute bronchoconstrictor response.This publication has 20 references indexed in Scilit:
- Strain difference in an allergic asthma model in rats.The Japanese Journal of Pharmacology, 1987
- EFFECTS OF INHALED PLATELET ACTIVATING FACTOR ON PULMONARY FUNCTION AND BRONCHIAL RESPONSIVENESS IN MANThe Lancet, 1986
- Cardiovascular and pulmonary activity of platelet-activating factor (PAF-Acether) and its derivativesPharmacological Research Communications, 1986
- Inhibition of Rhesus Monkey Airway and Cutaneous Responses to Platelet-Activating Factor (PAF) (AGEPC) with the Anti-PAF Agent SRI 63-072International Archives of Allergy and Immunology, 1986
- Platelet-activating factor todayTrends in Pharmacological Sciences, 1983
- Dependency of the Paf-acether induced bronchospasm on the lipoxygenase pathway in the guinea-pigProstaglandins, 1983
- Inhibition by sulphinpyrazone of the platelet-dependent bronchoconstriction due to platelet-activating factor (PAF-acether) in the guinea-pigEuropean Journal of Pharmacology, 1982
- Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivativesEuropean Journal of Pharmacology, 1980
- LEUKOCYTE-DEPENDENT HISTAMINE RELEASE FROM RABBIT PLATELETSThe Journal of Experimental Medicine, 1972
- Versuchsanordnung zu Untersuchungen an der BronchiàlmuskulaturNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1940